Home › Free Stock Grades › ANAB
AnaptysBio, Inc. (ANAB) Stock Grade
ANAB · Healthcare
A+
Market Cap
$898.1M
P/E Ratio
—
Revenue Growth (YoY)
+157.0%
Net Margin
-5.6%
Return on Equity
—
Dividend Yield
None
About AnaptysBio, Inc.'s fundamentals
AnaptysBio is a biotechnology company with an $898.1 million market capitalization that reported exceptional revenue growth of 157% year-over-year, indicating rapidly expanding commercial traction. Despite this strong top-line expansion, the company operates at a net loss with a -5.6% net margin, reflecting typical cash burn patterns for growth-stage biotech firms. Notably, the company generated positive free cash flow in its latest period despite reporting an accounting loss, suggesting operational improvements and potential progress toward cash flow breakeven. The company does not currently pay a dividend.